Natixis Advisors
DXCM icon

Natixis Advisors’s DexCom DXCM Stock Holding History

Natixis Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
33,520
-2,566
-7% -$171K ﹤0.01% 1180
2026
Q1 		$2.27M Buy
36,086
+8,025
+29% +$559K ﹤0.01% 1073
2025
Q4 		$1.86M Sell
28,061
-81,203
-74% -$5.25M ﹤0.01% 1067
2025
Q3 		$7.35M Sell
109,264
-117,827
-52% -$9.32M 0.01% 743
2025
Q2 		$19.8M Buy
227,091
+76,147
+50% +$5.97M 0.03% 479
2025
Q1 		$10.3M Sell
150,944
-42,588
-22% -$3.48M 0.02% 627
2024
Q4 		$15.1M Buy
193,532
+158,124
+447% +$11.7M 0.03% 534
2024
Q3 		$2.37M Sell
35,408
-1,056,986
-97% -$86.8M ﹤0.01% 1040
2024
Q2 		$124M Sell
1,092,394
-63,606
-6% -$8.04M 0.27% 81
2024
Q1 		$160M Buy
1,156,000
+26,430
+2% +$3.32M 0.37% 54
2023
Q4 		$140M Buy
1,129,570
+661,584
+141% +$67.6M 0.37% 53
2023
Q3 		$43.7M Buy
467,986
+413,407
+757% +$46.6M 0.13% 172
2023
Q2 		$7.01M Buy
54,579
+2,295
+4% +$278K 0.02% 619
2023
Q1 		$6.07M Buy
52,284
+11,683
+29% +$1.31M 0.02% 637
2022
Q4 		$4.6M Buy
40,601
+6,736
+20% +$740K 0.02% 703
2022
Q3 		$2.73M Sell
33,865
-3,054
-8% -$259K 0.01% 811
2022
Q2 		$2.75M Buy
+36,919
New +$3.37M 0.01% 811
2014
Q3 		– Sell
-27,508
Closed -$273K – 1060
2014
Q2 		$273K Buy
27,508
+6,240
+29% +$55.3K ﹤0.01% 1184
2014
Q1 		$220K Buy
+21,268
New +$220K ﹤0.01% 1173

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Natixis Advisors's DXCM Position: Q2 2026 in Review

Natixis Advisors reduced its DexCom (DXCM) stake by 7.1% in Q2 2026, selling an estimated $171K and leaving 33,520 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1180.

Natixis Advisors first reported a position in DXCM in Q1 2014 and has held it in 19 quarters since. The position peaked at $160M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Natixis Advisors held 33,520 shares of DexCom worth $2.26M as of Q2 2026.
  • Natixis Advisors sold 2,566 DexCom shares in Q2 2026, an estimated $171K.
  • DexCom made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1180 holding.
  • Natixis Advisors first reported a position in DexCom in Q1 2014 and has held it in 19 quarters since.
  • Natixis Advisors's DexCom position peaked at $160M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.